DILIsym
Curated by SignalProvider of quantitative toxicology software for the drug development process
Overview
Provider of quantitative toxicology software for the drug development process. The company has developed software that provides drug modelling for liver injury diseases. It assists researchers to predict drug toxicology in the system for the patients. The system has the ability to analyse hazards that can be caused due to individual molecules in the drug. The system uses graphical interface fro the in silico investigation of the compounds, dose and duration of the drug interaction. The software is integrated with another tool called SomPops developed by the company that is a collection of simulated patients. SimPops allows the researcher to research inter-individual variability of the drug toxicity.
Key facts
- Founded
- 2014
- Headquarters
- Durham, United States
- Stage
- Sign up to view
- Industry
- Health Technology
Business model
- 1 product or service
- Sign up to view